I'm tired of people saying the trials failed.
they didn't, some of you really need to stop being so ignorant.
CHF didn't meet the primary endpoint of re-hospitalisation but it smashed the secondary endpoints at 60% reduced mortality how is that a fail? - I see this either getting approved straight up or approval with another confirmatory study.
COVID ARDS - trial ended at the third analysis because DSMB said "may not reach primary endpoint of 43% reduction in mortality"
firstly, since April, the UK has 10x the amount of COVID cases
and 50% less deaths than it did in April, the standard of care is increasing to the point where it makes it hard to distinguish what is, and isn't working43% was also optimistic, MSCs role in repairing the damage don
by COVID is what the secondary endpoints will be looking at, again not a fail if the trial shoes impressive lung repairAlso, the DSMBs job is to ensure the trial continues its course (this point 43% reduction in mortality) the fact it ended means that in the third analysis it did not reach this number, so it's ending the trial, we may still may see 20-30% reduction in mortality while accelerating recovery (which is what we saw during the pilot study, i.e days of ventilators)
srGVHD - again, not a fail, FDA want a "confirmatory study" before approval, who knows? We might see conditional approval based on the TA meeting
- Forums
- ASX - By Stock
- MSB
- You wanna play with FIRE?
You wanna play with FIRE?, page-133
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B |
Open | High | Low | Value | Volume |
$1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 5460 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.26 | 978 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 5460 | 1.250 |
3 | 38390 | 1.245 |
4 | 165443 | 1.240 |
3 | 125898 | 1.235 |
6 | 135812 | 1.230 |
Price($) | Vol. | No. |
---|---|---|
1.255 | 978 | 1 |
1.260 | 191681 | 5 |
1.265 | 127480 | 6 |
1.270 | 136662 | 4 |
1.275 | 146158 | 3 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online